IDEXX Laboratories (IDXX) Revenue & Revenue Breakdown
IDEXX Laboratories Revenue Highlights
Latest Revenue (Y)
$3.66B
Latest Revenue (Q)
$1.00B
Main Segment (Y)
Product
Main Geography (Y)
Americas
IDEXX Laboratories Revenue by Period
IDEXX Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.66B | 8.72% |
| 2022-12-31 | $3.37B | 4.73% |
| 2021-12-31 | $3.22B | 18.79% |
| 2020-12-31 | $2.71B | 12.45% |
| 2019-12-31 | $2.41B | 8.75% |
| 2018-12-31 | $2.21B | 12.40% |
| 2017-12-31 | $1.97B | 10.91% |
| 2016-12-31 | $1.78B | 10.83% |
| 2015-12-31 | $1.60B | 7.81% |
| 2014-12-31 | $1.49B | 7.90% |
| 2013-12-31 | $1.38B | 6.47% |
| 2012-12-31 | $1.29B | 6.13% |
| 2011-12-31 | $1.22B | 10.45% |
| 2010-12-31 | $1.10B | 6.96% |
| 2009-12-31 | $1.03B | 0.74% |
| 2008-12-31 | $1.02B | 11.00% |
| 2007-12-31 | $922.55M | 24.82% |
| 2006-12-31 | $739.12M | 15.83% |
| 2005-12-31 | $638.10M | 16.19% |
| 2004-12-31 | $549.18M | 15.38% |
| 2003-12-31 | $475.99M | 15.34% |
| 2002-12-31 | $412.67M | 6.89% |
| 2001-12-31 | $386.08M | 5.08% |
| 2000-12-31 | $367.43M | 3.15% |
| 1999-12-31 | $356.20M | 11.35% |
| 1998-12-31 | $319.90M | 21.63% |
| 1997-12-31 | $263.00M | -1.76% |
| 1996-12-31 | $267.70M | 41.94% |
| 1995-12-31 | $188.60M | 49.21% |
| 1994-12-31 | $126.40M | 35.77% |
| 1993-12-31 | $93.10M | - |
IDEXX Laboratories generated $3.66B in revenue during NA 2023, up 8.72% compared to the previous quarter, and up 165.41% compared to the same period a year ago.
IDEXX Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.00B | 4.10% |
| 2024-03-31 | $964.10M | 6.93% |
| 2023-12-31 | $901.60M | -1.52% |
| 2023-09-30 | $915.53M | -2.98% |
| 2023-06-30 | $943.63M | 4.83% |
| 2023-03-31 | $900.20M | 8.64% |
| 2022-12-31 | $828.57M | -1.56% |
| 2022-09-30 | $841.66M | -2.19% |
| 2022-06-30 | $860.55M | 2.87% |
| 2022-03-31 | $836.55M | 4.43% |
| 2021-12-31 | $801.09M | -1.15% |
| 2021-09-30 | $810.42M | -1.90% |
| 2021-06-30 | $826.14M | 6.23% |
| 2021-03-31 | $777.71M | 7.87% |
| 2020-12-31 | $720.94M | -0.12% |
| 2020-09-30 | $721.79M | 13.21% |
| 2020-06-30 | $637.59M | 1.80% |
| 2020-03-31 | $626.34M | 3.45% |
| 2019-12-31 | $605.45M | 0.02% |
| 2019-09-30 | $605.30M | -2.39% |
| 2019-06-30 | $620.10M | 7.65% |
| 2019-03-31 | $576.06M | 4.85% |
| 2018-12-31 | $549.39M | 0.72% |
| 2018-09-30 | $545.45M | -6.08% |
| 2018-06-30 | $580.75M | 8.02% |
| 2018-03-31 | $537.66M | 6.23% |
| 2017-12-31 | $506.12M | 2.88% |
| 2017-09-30 | $491.98M | -3.33% |
| 2017-06-30 | $508.94M | 10.16% |
| 2017-03-31 | $462.02M | 4.29% |
| 2016-12-31 | $443.00M | -1.18% |
| 2016-09-30 | $448.31M | -3.91% |
| 2016-06-30 | $466.57M | 11.74% |
| 2016-03-31 | $417.55M | 4.47% |
| 2015-12-31 | $399.69M | -1.65% |
| 2015-09-30 | $406.39M | -1.68% |
| 2015-06-30 | $413.34M | 8.07% |
| 2015-03-31 | $382.48M | 8.67% |
| 2014-12-31 | $351.96M | -8.23% |
| 2014-09-30 | $383.52M | -1.69% |
| 2014-06-30 | $390.12M | 8.31% |
| 2014-03-31 | $360.20M | 1.73% |
| 2013-12-31 | $354.07M | 4.66% |
| 2013-09-30 | $338.30M | -4.05% |
| 2013-06-30 | $352.58M | 6.17% |
| 2013-03-31 | $332.11M | 3.93% |
| 2012-12-31 | $319.54M | 1.29% |
| 2012-09-30 | $315.48M | -6.01% |
| 2012-06-30 | $335.65M | 4.02% |
| 2012-03-31 | $322.68M | 5.04% |
| 2011-12-31 | $307.20M | 2.08% |
| 2011-09-30 | $300.95M | -5.32% |
| 2011-06-30 | $317.86M | 8.61% |
| 2011-03-31 | $292.67M | 3.14% |
| 2010-12-31 | $283.76M | 5.24% |
| 2010-09-30 | $269.63M | -4.21% |
| 2010-06-30 | $281.48M | 4.83% |
| 2010-03-31 | $268.52M | -0.67% |
| 2009-12-31 | $270.33M | 4.33% |
| 2009-09-30 | $259.12M | -2.48% |
| 2009-06-30 | $265.72M | 12.38% |
| 2009-03-31 | $236.46M | -2.81% |
| 2008-12-31 | $243.29M | -3.11% |
| 2008-09-30 | $251.09M | -10.51% |
| 2008-06-30 | $280.57M | 12.65% |
| 2008-03-31 | $249.07M | 1.68% |
| 2007-12-31 | $244.97M | - |
IDEXX Laboratories generated $1.00B in revenue during Q2 2024, up 4.10% compared to the previous quarter, and up 111.48% compared to the same period a year ago.
IDEXX Laboratories Revenue Breakdown
IDEXX Laboratories Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Product | $2.09B | $1.93B | $1.88B | $1.59B | $1.42B |
| Service | $1.57B | $1.44B | $1.34B | $1.12B | $983.76M |
| Reagent Rental Programs | - | $42.80M | $38.30M | - | - |
| Instrument Rebate Programs | - | $12.00M | $14.30M | - | - |
| Extended Warranties And Post Contract Support | - | $11.30M | $16.00M | - | - |
| Up Front Customer Loyalty Programs And Volume Commitment Programs | - | $3.20B | $2.90B | - | - |
IDEXX Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (57.09%), and Service (42.91%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $421.05M | $773.81M | $402.95M | $394.25M | $351.69M | $360.66M | $368.03M | $358.17M | $332.63M | $338.63M | $345.43M | $323.36M | $287.24M | $299.51M | $271.53M | $261.56M | $242.00M | $245.30M | $254.47M | - |
| Product | $543.05M | $1.04B | $540.68M | $505.94M | $476.87M | $481.00M | $492.52M | $478.38M | $468.46M | $471.79M | $480.71M | $454.35M | $433.69M | $422.28M | $366.06M | $364.77M | $363.45M | $360.00M | $365.64M | - |
| Reagent Rental Programs | - | - | $51.00M | $35.90M | $37.20M | $39.10M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Extended Warranties And Post Contract Support | - | - | $9.60M | $1.90M | $11.70M | $14.40M | $2.30M | $17.10M | - | - | - | - | - | - | - | - | - | - | - | - |
| Instrument Rebate Programs | - | - | $2.20M | $2.70M | $2.90M | $3.40M | $3.30M | $3.50M | - | - | - | - | - | - | - | - | - | - | - | - |
| Up Front Customer Loyalty Programs And Volume Commitment Programs | - | - | $2.90B | $3.00B | $3.00B | $2.70B | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
IDEXX Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (56.33%), and Service (43.67%).
IDEXX Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| CANADA | $150.11M | $142.74M | $107.40M | $99.55M | - |
| Asia Pacific Region, Other | $104.11M | $68.21M | $61.05M | - | - |
| Americas | $2.63B | $1.85B | $1.65B | - | - |
| AUSTRALIA | $95.47M | $79.63M | $71.07M | - | - |
| UNITED STATES | $2.39B | $1.69B | $1.50B | - | - |
| SWITZERLAND | $34.83M | $30.65M | $31.98M | $24.85M | $20.86M |
| EMEA | $716.18M | $562.76M | $498.44M | - | - |
| CHINA | $44.17M | $70.84M | $57.52M | - | - |
| Asia Pacific | $319.31M | $293.40M | $256.89M | - | - |
| SPAIN | $52.33M | $39.27M | $36.44M | - | - |
| NETHERLANDS | $30.51M | $23.46M | $19.40M | - | - |
| Latin America and Caribbean | $83.92M | - | - | - | - |
| JAPAN | $75.57M | $74.72M | $67.25M | - | - |
| ITALY | $53.79M | $42.82M | $39.73M | - | - |
| GERMANY | $149.79M | $119.35M | $104.08M | - | - |
| FRANCE | $96.80M | $74.81M | $64.77M | - | - |
| Europe, the Middle East, and Africa, Other | $176.40M | $148.05M | $122.21M | - | - |
| Latin America | - | - | - | $51.86M | $56.52M |
IDEXX Laboratories's latest annual revenue breakdown by geography, as of Dec 23: Americas (36.46%), UNITED STATES (33.21%), EMEA (9.95%), Asia Pacific (4.43%), Europe, the Middle East, and Africa, Other (2.45%), CANADA (2.08%), GERMANY (2.08%), Asia Pacific Region, Other (1.45%), FRANCE (1.34%), AUSTRALIA (1.33%), Latin America and Caribbean (1.17%), JAPAN (1.05%), ITALY (0.75%), SPAIN (0.73%), CHINA (0.61%), SWITZERLAND (0.48%), and NETHERLANDS (0.42%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Latin America | $20.24M | $22.30M | $17.07M | $16.39M | $15.58M | $15.67M | $13.65M | $10.52M | $12.03M | $15.00M | $14.09M | $14.70M | - | - | - | - | - | - | - | - |
| Asia Pacific | $76.30M | $186.48M | $77.67M | $80.10M | $83.86M | $84.73M | $78.24M | $83.62M | $84.78M | $80.74M | $77.40M | $71.75M | $63.51M | $68.13M | $64.65M | $64.03M | - | - | - | - |
| UNITED STATES | $631.01M | $671.83M | $603.05M | $559.83M | $525.91M | $493.46M | $514.34M | $515.24M | $472.64M | $433.61M | $454.84M | $406.00M | $396.78M | $368.17M | $380.18M | $388.88M | - | - | - | - |
| CANADA | $36.71M | $36.90M | $35.61M | $41.63M | $35.96M | $34.34M | $33.64M | $39.53M | $35.23M | $34.12M | $32.81M | $39.34M | $33.46M | $29.08M | $28.71M | $25.36M | $24.25M | $24.34M | $24.33M | $27.65M |
| EMEA | $199.83M | $183.66M | $177.85M | $161.99M | $173.81M | $171.19M | $167.96M | $171.55M | $171.25M | $161.84M | $147.19M | $123.97M | $129.77M | - | - | - | - | - | - | - |
| Latin American and Caribbean | - | - | $21.35M | $19.09M | $17.74M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Europe Middle East And Africa | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $122.05M | $124.84M |
IDEXX Laboratories's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (65.45%), EMEA (20.73%), Asia Pacific (7.91%), CANADA (3.81%), and Latin America (2.10%).
IDEXX Laboratories Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TMO | Thermo Fisher Scientific | $42.86B | $10.54B |
| IQV | IQVIA | $14.98B | $3.81B |
| DHR | Danaher | $14.03B | $3.43B |
| ICLR | ICON Public Limited Company | $8.12B | $2.09B |
| A | Agilent | $6.83B | $1.58B |
| ILMN | Illumina | $4.50B | $1.08B |
| CRL | Charles River Laboratories | $4.13B | $1.03B |
| MTD | Mettler-Toledo | $3.79B | $946.75M |
| IDXX | IDEXX Laboratories | $3.66B | $1.00B |
| WAT | Waters | $2.96B | $708.53M |
| RVTY | Revvity | $2.75B | $691.68M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
IDXX Revenue FAQ
What is IDEXX Laboratories’s yearly revenue?
IDEXX Laboratories's yearly revenue for 2023 was $3.66B, representing an increase of 8.72% compared to 2022. The company's yearly revenue for 2022 was $3.37B, representing an increase of 4.73% compared to 2021. IDXX's yearly revenue for 2021 was $3.22B, representing an increase of 18.79% compared to 2020.
What is IDEXX Laboratories’s quarterly revenue?
IDEXX Laboratories's quarterly revenue for Q2 2024 was $1B, a 4.10% increase from the previous quarter (Q1 2024), and a 6.35% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $964.1M, a 6.93% increase from the previous quarter (Q4 2023), and a 7.10% increase year-over-year (Q1 2023). IDXX's quarterly revenue for Q4 2023 was $901.6M, a -1.52% decrease from the previous quarter (Q3 2023), and a 8.81% increase year-over-year (Q4 2022).
What is IDEXX Laboratories’s revenue growth rate?
IDEXX Laboratories's revenue growth rate for the last 3 years (2021-2023) was 13.86%, and for the last 5 years (2019-2023) was 52.10%.
What are IDEXX Laboratories’s revenue streams?
IDEXX Laboratories's revenue streams in c 23 are Product, and Service. Product generated $2.09B in revenue, accounting 57.09% of the company's total revenue, up 8.36% year-over-year. Service generated $1.57B in revenue, accounting 42.91% of the company's total revenue, up 9.21% year-over-year.
What is IDEXX Laboratories’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of IDEXX Laboratories was Product. This segment made a revenue of $2.09B, representing 57.09% of the company's total revenue.